Sunshine Biopharma (SBFMW) Operating Income Growth (1y) (2012 - 2026)
Sunshine Biopharma (SBFMW) Operating Income Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn | 25.63% |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn | -1.30% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -14.89% |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn | 719.49% |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn | 117.78% |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn | 23.29% |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn | -450.06% |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn | -20.32% |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn | 273.62% |
| 10 | Sunshine Biopharma | - | - | 2.18 Mn | -7.71% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.71% |
| Dec 31, 2025 | 12.16% |
| Sep 30, 2025 | 1.78% |
| Jun 30, 2025 | -62.00% |
| Mar 31, 2025 | 4.06% |
| Dec 31, 2024 | -71.64% |
| Sep 30, 2024 | -41.94% |
| Jun 30, 2024 | -25.09% |
| Mar 31, 2024 | 26.16% |
| Dec 31, 2023 | 94.92% |
| Sep 30, 2023 | 54.63% |
| Jun 30, 2023 | -45.72% |
| Mar 31, 2023 | -49.50% |
| Dec 31, 2022 | -8,255.16% |
| Sep 30, 2022 | -246.19% |
| Jun 30, 2022 | -79.05% |
| Mar 31, 2022 | 4.10% |
| Dec 31, 2021 | 18.55% |
| Sep 30, 2021 | -637.51% |
| Jun 30, 2021 | -202.25% |